Taking peopleNo phase
Outcome of the Semibranch in Pararenal and Thoracoabdominal Aortic Pathologies. A Prospective, Multicentre Registry.
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University Hospital Muenster
- Trial code
- NCT06059053
- Record updated
- 26 March 2024
- Original description
The goal of this registry is to evaluate the semibranch in branched endovascular aortic repair, which is a new tool in endovascular branched aortic repair.Read full original descriptionShow less
The goal of this registry is to evaluate the semibranch in branched endovascular aortic repair, which is a new tool in endovascular branched aortic repair.
Inclusion: 18 years or older; Presence of pararenal or thoracoabdominal aortic pathology; Treatment planned a semibranch device branch from Artivion; Availability of the patients during the follow up period; Informing patients about the study and providing written informed consent.
Exclusion: Women of childbearing age; Patients under 18 years.